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Tunicamycin, an inhibitor of the asparagine-linked protein N-glycosylation, blocks the initiation of DNA synthesis in Swiss 3T3 cells stimulated 
by prostaglandin F,, alone or with insulin. This effect is exerted only when tunicamycin is added from 0 to 8 h after stimulation and it decreases 
the rate of entry into S phase. Elocking of labeled sugar incorporation to proteins occurs regardless of the time of PGF& stimulation. In contrast 
tunicamicin dqes not inhibit protein synthesis. These results suggest hat N-glycoprotein synthesis early during the prerephcative phase is an 
important event controlling the mitogenic action of @GFr,. 
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1. INTRODUCTION 
Pcaammalian cell proliferation involves the expression 
of a reproducible program of signals and intracellular 
events which precede the onset of DNA replication [l- 
33. Postranslational protein modifications have been 
shown to be involved in the regulation of cell division 
[4J. The N-glycosylation of newly synthesized proteins 
plays an important role in controlling embryonic devel- 
opment, cell differentiation and proliferation [5-143. 
N-Glycosylation involves several metabolic steps 
leading to the formation of the dolichol core oligosac- 
charide and its transference to the nascent polypeptide 
chains [15]. Tunisamycin (TM) inhibits the first step of 
the N-glycosylation process [16] and thereby alters 
many cellular processes [5-l 11. 
cultured Swiss mouse 3T3 cells have provided a use- 
ful model system to study the mechanisms that regulate 
proliferation [1’7]. These cells can be arrested in the 
GdG, phase of the cell cycle upon serum deprivation or 
when allowed to become coniluent [2,3]. Addition to 
such cultures of serum or a variety of growth factors, 
including prostaglandin F,, (PGF,,), stimulates the ini- 
tiation of DWA synthesis after a constant lag phase of 
14-15 h [2,3]. The rate of entry into S phase follows 
apparent first-order kinetics and can be quantified by 
a rate constant K [l&,19]. 
Here we show that in confluent resting Swiss mouse 
3T3 cells stimulated by PGF2, without or with insulin, 
TM inhibits the initiation of DNA synthesis, only if 
added within the first 8 h after mitogenic induction. 
Nevertheless, TRI does reduce the incorporation of 
[‘4C]glucosamine and [31iJmannose into total cellular 
protein at any time after stimulation. These results sug- 
pest that M-glycoprotein synthesis early during the lag 
phase plays an important role in the mitogenic response 
of PGF,,. 
2. MATERIALS AND METI-IODS 
2.1. Cell culture, initiation of DNA synthesis assay and determination 
of rate constanl for entry into S phase 
Cell culture, conditions for the assay of DNA synthesis, labeling 
with [methyl-3H]thymidine and autoradiography were performed as 
previously described [ 191. The value of the rate constant K for entry 
into S phase was calculated as before [19]. 
2.2. Glucosamine, mannose and leucine incorporation 
Cells were plated as for the assay of DNA synthesis [19]. For sugar 
labeling, the culture medium was removed and the cells were washed 
twice with 2.0 ml of serum-free medium minus glucose pre-warmed to 
37% The cells then received 2.0 ml of the same medium containing 
the different stimuli and were labeled with 25 yM [‘4C]glucosamine (I 
yCi/ml) and 50 ,KM [‘PI] mannose (2.5 &i/ml) as indicated. For pro- 
tein synthesis, stimulated cultures were exposed to [3H]leucine (2.5 
,uCi/ml). Thereafter, cells were processed and radioactivity was 
counted as described before [131. 
2.3. Matet=ials 
PGF,, was the generous gift of Dr. John Pike, Upjohn Co. All 
remaining chemicals were purchased from Sigma. D-[t-“H]mannose 
(IO-20 Wmmol), D-[N-‘4C]glucosamine hydrochloride (250-350 mCi/ 
mmol), L-[4,5-‘HJleucine (130 Wmmol) and [methyl-3H]thymidine (18
Wmmol) were from the Radiochemical Center Amersham. 
Abbreviations: PGF*,, prostaglandin F2u; TM, tunicamycin. 3. RESULTS 
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Fig. I. (A) Effect of TM on the stimulation of DNA synthesis by 
PGF2. (300 @ml) without or with insulin (60 @ml). (0). PGF2, plus 
TM; (e), PGF2,, plus insulin and TM; (o), TM; (o), TM plus insulin. 
(B) Effect of TM (250 ng/ml) added at different times after PGF,, (300 
@ml) without or with insulin (60 n&ml) on the stimulation of DNA 
synthesis. (0). PGFt. with TM; (e), PGFzD with insulin plus TM. 
Cultures were labeled for autoradiography from 0 to 28 h after addi- 
tions as indicated in Materials and Methods. 
is shown in Fig. IA. PGF2, (300 q/ml) added to con- 
fluent resting Swiss 3T3 cells stimulates the initiation of 
DNA synthesis, resulting in 20% of labeled nuclei after 
28 h (Fig. 1A). Insulin (60 q/ml) which is non-mitoge- 
nis in these cells [17] enhances the stimulation of PGF,,, 
by increasing the labeled index up to 50%. TM (50-1000 
ngIm1) alone or with insulin had no effect on the initia- 
tion of DNA synthesis but when added with PGF,, or 
PGF,, plus insulin it inhibited the mitogenic response 
(Fig. IA). 
TM (250 ng/ml) added at different times after PGF,, 
alone or with insulin markedly inhibits the initiation of 
DNA synthesis only within the first 2 h of mitogenic 
induction. Addition of TM at later times resulted in a 
progressive loss of its effect (Fig. 1B). It disappeared 
when TM was added at 8-13 h after stimulation, and 
the labeling index obtained was similar to that observed 
in the absence of TM (Fig. 1B). 
Stimulation of Swiss 3T3 cells by PGF,, (300 q/ml) 
increases the value of the rate constant K for cellular 
entry into S phase after a lag of 15 h (Fig. 2A). Insulin 
only potentiates the effect of PGFzo, by increasing the 
value of K. TM (250 ng/ml) added with PGF2, alone or 
with insulin reduced the value of K without changing 
the length of the lag phase (Fig. 2A,B). In contrast, TM 
added at 8 or al 13 h after stimulation did not alter the 
rate of entry into S phase (Fig. 2A,B). 
3.3. EjJect of tunicamycin on [‘4Cjglucosamine, 
[3H]munnose and [‘H]leucine incorporation 
The effect of PGF2, minus or plus insulin in the incor- 
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Fig. 2. Kinetics of entry into S phase stimulated by PGF,, (300 @ml) 
without or with insulin (60 @ml) and in the absence of presence of 
TM (250 n&ml). (A) (x). no addition (K = 0.05); (o), insulin (K = 
0.06); (A), PGFzo (K = 1.3); (A), PGF2, plus TM added at 0 h (K = 
0.3); (*), PGF2. plus TM added at 8 h (K = 1.4); (e), PGF2,, plus TM 
added at 13 h (K = 1.5). (B) (W TM (K = 0.05); (P), TM plus insulin 
(K = 0.05); (A), PGFzp, with insulin (X = 5.3); (@), PGF,, with insulin 
and TM added at 0 h (K = I .2); (o), PGFI, plus insulin and TM added 
at 8 h (K = 5.4); (o), PGF*, with insulin and TM added at 13 h (K = 
5.4); (@), fetal calf serum (K = 24.0). K values are given in IO-* h. In 
all cases the duration of the lag phase was 15 h. Labeling procedures 
as in Fig. 1. 
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Fig. 3. Efect of TM [‘4C]glucosamine and [%I]mannose incorporation 
stimulated by PGF,, (300 &ml) alone or with insulin (60 ng/ml). (o), 
PGF,, plus TM; (P), PGF2. plus insulin and TM; (e), insulin plus 
TM; (o), TM. Cells were radioactively labeled as indicated in Ma- 
terials and Methods. 
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Table I 
Comparison of TM effect on DNA synthesis, [-‘H]mannose and [‘HI- 
leuciae incorporation at different times of the lag phase upon stimula- 
tion by PGF2, minus or plus insulin 
.~ 
This includes surface membrane receptors for growth 
factors [22], hormones [7,8] or neurotransmitters [2 11, as 
well as fibronectin [23] or proteins participating in cell 
fusion [9]. 
A 
Additions Labeled 
nuclei 
TpyE!n;;;; ;iWjkiu;;; 
(X 104) . . (%) (x 104) 
none 0.5 1.4 8.4 
PGF?, 22.6 8.4 13.3 
PGF2. + TM 22.9 2.9 12.9 
PGF2, + insulin 55.1 12.6 15.6 
PGF,, + insulin + TM 54.3 4.3 15.7 
eclls were stimulated by PGF, (300 @ml) without or with insulin 
(SO @ml). TM (250 @ml) was added at different times after stimula- 
tion: (A) initiation of DNA synthesis from 9 to 28 h; (&) incorporation 
of [‘HJmannose from 9 to 14 h; (C) [3H]leucine incorporation, from 
0 to 5 h. Measurements were as indicated in Materials and Methods. 
poration of [‘4C]glucosamine and [3H]mannose into 
total cellular proteins is shown in Fig. 3. Addition of 
PGF,, (300 ng/ml) increases the incorporation of 
[‘4C]glucosamine and [3H]mannose into acid-precipita- 
ble material. Insulin had a small effect on the incorpora- 
tion of these sugars but together with PGFza enhances 
it. TM added at 50-1000 ng/ml reduces the incorpora- 
tion of either [‘4C]glucosamine and [3H]mannose stimu- 
lated by PGFzB, insulin or PGF,, with insulin (Fig. 3). 
Also TM (250 @/ml) added from 9 to 14 h after PGF,,, 
minus or plus insulin inhibited the incorporation of 
[3H]mannose, without affecting the initiation of DNA 
synthesis. Pn contrast, TM addition from 0 to 5 h to 
stimulated cells did not block [31-l]leucine incorporation 
into cellular proteins (Table I). 
4. DISCUSSION 
Previous findings indicated that N’-glycoproteins 
synthesis plays an important role in the control of cell 
division [ 11,141. The division of Burkitt lymphoma cells 
can be arrested by TM in G,,G, phase of the cell cycle 
[I 11. TM removal enables these cells to synthesize three 
major N’-glycoproteins prior to their entry into S phase 
[ 111. Also TM reduces the proliferation and DNA poly- 
merase 01~ activity in neuroblastoma cells [20]. Other 
results show that division of exponentially growing 
Swiss 3T3 cells can be reversibly blocked by TM [lo]. 
In contrast, TM did not affect the division of polyoma 
3T3 and SV40 W138 transformed cells, but it caused 
cytotoxicity and changes in their agglutinability [IO]. In 
addition, it has been shown that TM inhibits the initia- 
tion of DNA synthesis in quiescent Swiss 3T3 cells sti- 
mulated by serum [14]. 
Other evidence reveals that TM treatment of a variety 
OF cells decreases the presence and/or alters the proper- 
ties of many N’-glycoproteins, some of them due to 
increased sensitivity to proteolytic degradation [21]. 
Here we have shown that TM inhibits the initiation 
of DNA synthesis in Swiss 3T3 cells stimulated by 
PGF,, alone or with insulin. The effect of TM is accom- 
panied by a decrease of [‘4C]glucosamine and [3H]man- 
nose but not f3H]leucine incorporation into total cell 
proteins indicating that it is probably due to the bloc- 
kage of the N’-glycosylation process and not of protein 
synthesis. Furthermore, TM inhibits the rate of entry 
into S phase only when added within the first 8 h of the 
lag phase regardless of blocking sugar incorporation at 
any time after stimulation. Thus it appears that N’- 
glycoprotein synthesis early in the lag phase is a crucial 
event to regulate the initiation of DNA synthesis in- 
duced by PGF2, and possibly by other mitogens. The 
identification of these N’-glycoproteins, is the frame- 
work of our future research. 
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